4.7 Article

Complexity of the Immune Response Elicited by Different COVID-19 Vaccines, in the Light of Natural Autoantibodies and Immunomodulatory Therapies

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Immunology

Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination

Pascal Irrgang et al.

Summary: RNA vaccines are effective in preventing SARS-CoV-2 infection, and high levels of neutralizing antibodies are crucial for vaccine-induced immunity. After the second mRNA vaccination, SARS-CoV-2-specific antibodies were increasingly composed of noninflammatory IgG4, which was further boosted by a third vaccination or breakthrough infections. This induction of IgG4 antibodies was not observed with adenoviral vectors. These findings have implications for the choice and timing of mRNA vaccine regimens, including booster shots.

SCIENCE IMMUNOLOGY (2023)

Review Biochemistry & Molecular Biology

Blocking TNF signaling may save lives in COVID-19 infection

Vitaly Ablamunits et al.

Summary: The global vaccination effort and improved treatment strategies offer hope for combating the COVID-19 pandemic. However, the disease continues to cause significant mortality in many countries. The burst of pro-inflammatory cytokines, particularly TNF, plays a major role in severe cases and multiple organ failure. Pharmaceutical agents that prevent TNF binding or block TNF signaling pathways show promise in clinical trials.

MOLECULAR BIOLOGY REPORTS (2022)

Article Immunology

Trajectory of IgG to SARS-CoV-2 After Vaccination With BNT162b2 or mRNA-1273 in an Employee Cohort and Comparison With Natural Infection

Behnam Keshavarz et al.

Summary: This study investigated the durability of immune response elicited by BNT162b2, mRNA-1273, and Ad26.COV2.S vaccines. The results showed that the IgG levels induced by BNT162b2 and mRNA-1273 were similar between 7 to 20 days after the second vaccination, but the IgG levels induced by BNT162b2 were lower than mRNA-1273 from day 21 onwards. Age was found to be a significant modifier of IgG levels in BNT162b2 recipients. After six months, the IgG levels induced by BNT162b2 were lower than those in COVID-19 patients who had been hospitalized six months earlier, while mRNA-1273 did not show the same decline. The differential IgG decay may contribute to the observed differences in clinical protection over time between BNT162b2 and mRNA-1273.

FRONTIERS IN IMMUNOLOGY (2022)

Article Immunology

Anti-TNFα Treatment Impairs Long-Term Immune Responses to COVID-19 mRNA Vaccine in Patients with Inflammatory Bowel Diseases

Keren Masha Rabinowitz et al.

Summary: Patients with inflammatory bowel disease (IBD) treated with anti-tumor-necrosis factor-alpha (TNF alpha) showed lower serologic responses to the COVID-19 BNT162b2 vaccine compared to those not treated with anti-TNF alpha or to healthy controls. The impaired responses in patients treated with anti-TNF alpha included more seronegativity, decreased specific circulating B cells, and reduced cross-reactivity. It is important to consider administering a booster dose of the vaccine earlier in these patients.

VACCINES (2022)

Review Materials Science, Biomaterials

Application of Monoclonal Antibody Drugs in Treatment of COVID-19: a Review

Aleksandra Kirillova et al.

Summary: Coronavirus infection has varying degrees of severity and outcomes, and the exact pathophysiology and treatment for severe cases are still uncertain. Preliminary studies suggest that immunosuppressive therapy can be considered for treatment, especially in severe cases. The review provides information on monoclonal antibody drugs, the pathogenesis of COVID-19, the host immune response, and the effects of immunosuppressive therapy in patients with autoimmune diseases who subsequently contract COVID-19.

BIONANOSCIENCE (2022)

Article Immunology

Relationship between natural and infection-induced antibodies in systemic autoimmune diseases (SAD): SLE, SSc and RA

K. Borocz et al.

Summary: The study explored the relationship between natural autoantibodies (nAAbs) and disease-specific antibodies in systemic autoimmune diseases, finding associations between certain antibody levels and disease- or infection-related antibodies. Significant differences were observed in different antibody isotypes among SLE patients, suggesting a potential link between immune response in autoimmune diseases and nAAbs.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2021)

Letter Cell Biology

Covid-19, heat shock proteins, and autoimmune bullous diseases: a potential link deserving further attention

Michael Kasperkiewicz

Summary: A potential link between Covid-19 and the development of autoimmune diseases has been suggested, possibly due to molecular similarities between SARS-CoV-2 and human proteins. Research has shown shared peptides between antigenic epitopes of the virus and heat shock proteins, indicating a possible autoimmune response.

CELL STRESS & CHAPERONES (2021)

Article Genetics & Heredity

SARS-CoV-2 Infection-Induced Promoter Hypomethylation as an Epigenetic Modulator of Heat Shock Protein A1L (HSPA1L) Gene

Jibran Sualeh Muhammad et al.

Summary: This study identified potential candidate genes that may be regulated by SARS-CoV-2 induced DNA methylation changes in COVID-19 infection, emphasizing the importance of epigenetic effects in this process.

FRONTIERS IN GENETICS (2021)

Review Cell Biology

The Pathophysiological Role of Heat Shock Response in Autoimmunity: A Literature Review

Ariadni Androvitsanea et al.

Summary: Research has shown that heat-shock proteins can have varying effects on the immune system, either triggering immune responses or alleviating them, which is important for studying and treating autoimmune diseases.
Review Medicine, General & Internal

Biologics for Psoriasis During the COVID-19 Pandemic

Huanhuan Zeng et al.

Summary: There is currently no consensus on whether biological agents increase the risk of coronavirus infection; however, current research shows that biological agents have no adverse effects on the prognosis of patients with COVID-19 and psoriasis. In short, it is not recommended to stop biological treatment in patients with psoriasis to prevent the infection risk, and decisions to pause biologic therapy for patients who tested positive for SARS-CoV-2 should be made on a case-by-case basis, taking into account individual risk and benefit. Vaccine immunization against SARS-CoV-2 is strongly recommended for psoriasis patients without discontinuation of their biologics, but assessing the risk-benefit ratio of maintaining biologics before vaccination is crucial at present.

FRONTIERS IN MEDICINE (2021)

Article Medicine, General & Internal

Psoriasis

Christopher E M Griffiths et al.

LANCET (2021)

Article Multidisciplinary Sciences

Diverse functional autoantibodies in patients with COVID-19

Eric Y. Wang et al.

Summary: COVID-19 patients show increased autoantibody reactivities against immunomodulatory proteins, which may affect immune function and lead to different clinical outcomes.

NATURE (2021)

Review Cell Biology

Diversity in heat shock protein families: functional implications in virus infection with a comprehensive insight of their role in the HIV-1 life cycle

Kruthika Iyer et al.

Summary: Heat shock proteins (HSPs) are cellular proteins induced during stress conditions, acting as chaperones that regulate protein folding and determine the fate of mis-folded/unfolded proteins. In viral infections, certain HSP isoforms play significant roles with varying pro-viral or anti-viral activities.

CELL STRESS & CHAPERONES (2021)

Review Biochemistry & Molecular Biology

Role of Heat Shock Proteins (HSP70 and HSP90) in Viral Infection

Anna Lubkowska et al.

Summary: Heat shock proteins (HSPs) are important molecular chaperones found in most eukaryotes and bacteria, responsible for maintaining cell homeostasis and assisting viral replication. HSP70 and HSP90 families are crucial for folding and replicating viral proteins, highlighting their potential in antiviral therapy.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Multidisciplinary Sciences

Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2

Dami A. Collier et al.

Summary: Elderly individuals, especially those above eighty, show lower immune responses and neutralization abilities against variants of concern after the first vaccine dose, but this improves after the second dose. They have higher frequencies of spike-specific memory B cells but reduced somatic hypermutation of class-switched cells. Production of interferon-gamma and interleukin-2 by SARS-CoV-2 spike-specific T cells is lower in older participants, predominantly by CD4 T cells.

NATURE (2021)

Article Multidisciplinary Sciences

New-onset IgG autoantibodies in hospitalized patients with COVID-19

Sarah Esther Chang et al.

Summary: In hospitalized COVID-19 patients, approximately 50% have detectable autoantibodies primarily targeting autoantigens associated with rare disorders. Additionally, a subset of autoantibodies develop de novo following SARS-CoV-2 infection.

NATURE COMMUNICATIONS (2021)

Article Chemistry, Medicinal

COVID-19: Does SARS-CoV-2 Modulate Acanthamoeba Epigenetics to Enhance Survival and Transmission in the Environment?

Jibran Sualeh Muhammad et al.

Summary: This study suggests the role of epigenetic mechanisms in the survival of SARS-CoV-2 inside Acanthamoeba and potential transmission through airborne cysts, offering new insights into the transmission mechanisms of the epidemic.

ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2021)

Article Allergy

Natural Antibodies: from First-Line Defense Against Pathogens to Perpetual Immune Homeostasis

Mohan S. Maddur et al.

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2020)

Review Biochemistry & Molecular Biology

Structural and functional analysis of the Hsp70/Hsp40 chaperone system

Qinglian Liu et al.

PROTEIN SCIENCE (2020)

Letter Dermatology

COVID-19 and immunomodulator/immunosuppressant use in dermatology

Kyla N. Price et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)

Letter Dermatology

Should biologics for psoriasis be interrupted in the era of COVID-19?

Mark Lebwohl et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)

Review Immunology

Covid-19 and autoimmunity

Michael Ehrenfeld et al.

AUTOIMMUNITY REVIEWS (2020)

Review Biochemistry & Molecular Biology

Heat Shock Protein 70 as a Double Agent Acting Inside and Outside the Cell: Insights into Autoimmunity

Stefan Tukaj

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Medicine, General & Internal

Does SARS-CoV-2 Trigger Stress-Induced Autoimmunity by Molecular Mimicry? A Hypothesis

Francesco Cappello et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Article Cardiac & Cardiovascular Systems

COVID-19 and hypertension: is the HSP60 culprit for the severe course and worse outcome?

Hrvoje Jakovac

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2020)

Article Medicine, General & Internal

Pandemrix-induced narcolepsy is associated with genes related to immunity and neuronal survival

Par Hallberg et al.

EBIOMEDICINE (2019)

Review Cell Biology

The Hsp70 chaperone network

Rina Rosenzweig et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)

Review Infectious Diseases

Developing the concept of beneficial non-specific effect of live vaccines with epidemiological studies

P. Aaby et al.

CLINICAL MICROBIOLOGY AND INFECTION (2019)

Review Microbiology

The Host Heat Shock Protein MRJ/DNAJB6 Modulates Virus Infection

Shih-Han Ko et al.

FRONTIERS IN MICROBIOLOGY (2019)

Review Immunology

Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction

Yahel Segal et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2018)

Article Allergy

Psoriasis pathogenesis and the development of novel targeted immune therapies

Jason E. Hawkes et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)

Article Immunology

Defining Natural Antibodies

Nichol E. Holodick et al.

FRONTIERS IN IMMUNOLOGY (2017)

Review Medicine, General & Internal

Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review

Julian P. T. Higgins et al.

BMJ-BRITISH MEDICAL JOURNAL (2016)

Review Medicine, General & Internal

Non-specific immunological effects of selected routine childhood immunisations: systematic review

Rama Kandasamy et al.

BMJ-BRITISH MEDICAL JOURNAL (2016)

Review Medicine, General & Internal

Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review

Julian P. T. Higgins et al.

BMJ-BRITISH MEDICAL JOURNAL (2016)

Review Medicine, General & Internal

Non-specific immunological effects of selected routine childhood immunisations: systematic review

Rama Kandasamy et al.

BMJ-BRITISH MEDICAL JOURNAL (2016)

Review Pharmacology & Pharmacy

Vaccines, adjuvants and autoimmunity

Luisa Eca Guimaraes et al.

PHARMACOLOGICAL RESEARCH (2015)

Article Medicine, General & Internal

Live Vaccine Against Measles, Mumps, and Rubella and the Risk of Hospital Admissions for Nontargeted Infections

Signe Sorup et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)

Review Immunology

Autoantibody repertoires, natural biomarkers, and system controllers

Irun R. Cohen

TRENDS IN IMMUNOLOGY (2013)

Review Immunology

A small jab - a big effect: nonspecific immunomodulation by vaccines

Christine S. Benn et al.

TRENDS IN IMMUNOLOGY (2013)

Article Immunology

Probiotics stimulate production of natural antibodies in chickens

Hamid R. Haghighi et al.

CLINICAL AND VACCINE IMMUNOLOGY (2006)

Article Immunology

Natural autoantibodies as tools to predict the outcome of immune response?

H Kohler et al.

SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2003)